Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 2Neoplasms 2Chronic Pain 1Agnosia 1

Interventions

Morphine 7Fentanyl 5Radiotherapy 4Methadone 4Zoledronic Acid 3Tapentadol 2Ropivacaine 2Pregabalin 2Prednisone 2Ketamine 2Ibandronic Acid 2Hydromorphone 2Glutamine 2Cryotherapy 2Cryosurgery 2Bupivacaine 2Acupuncture Therapy 2Acetaminophen 2pegfilgrastim 1oxycodone naloxone combination 1naloxegol 1ixabepilone 1incobotulinumtoxinA 1imisopasem manganese 1cyclobenzaprine 1cabozantinib 1acetaminophen, aspirin, caffeine drug combination 1Zolpidem 1Surveys and Questionnaires 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Pain × Tapentadol × Clear all
NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated
31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

NCT00505414 2019-11-01

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

Grünenthal GmbH

Phase 3 Terminated
136 enrolled 9 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡